| AASLD | American Association for the Study of Liver Diseases |
| ACAT1 | acyl-CoA: cholesterol acyltransferase 1 |
| ADA | American Diabetes Association |
| AFLD | alcoholic fatty liver disease |
| ALT | alanine aminotransferase |
| ApoE−/− | apolipoprotein E-deficient |
| ASH | alcohol-related steatohepatitis |
| BNP | brain natriuretic peptide |
| CAD | coronary artery disease |
| CI | confidence interval |
| CIDEB | cell death-inducing DFFA-like effector b |
| cIMT | carotid–intima media thickness |
| CK-18 | cytokeratine-18 |
| CRP | C-reactive protein |
| CT | computed tomography |
| CV | cardiovascular |
| CVD | cardiovascular diseases |
| CVOTs | cardiovascular outcome trials |
| DAMPs | damage-associated molecular patterns |
| DNL | de novo lipogenesis |
| DPP-4i | dipeptidyl dipeptidase-4 inhibitors |
| EASD | European Association for the study of Diabetes |
| EASL | European Association for the Study of Liver |
| ECs | endothelial cells |
| eNOS | endothelium nitric oxide synthase |
| ER | endoplasmic reticulum |
| ERK | extracellular signal-regulated kinase |
| FAO | fatty acid β-oxidation |
| FDA | Food and Drug Association |
| FFAs | free fatty acids |
| FibroScan | transient elastography |
| FOXO1 | forkhead transcription factor O1 |
| FXRs | farnesoid X receptors |
| GCKR | glucokinase regulator |
| GLP-1 RAs | glucagon-like peptide-1 receptor agonists |
| GPAM | glycerol-3-phosphate acyltransferase |
| GWAS | genome-wide association studies |
| HAECs | human aortic endothelial cells |
| HbA1(c) | glycated hemoglobin |
| HMGB-1 | high-mobility group protein 1 |
| hsCRP | high-sensitivity c-reactive protein |
| HSCs | hepatic stellate cells |
| 17β-HSD13 | hydroxysteroid 17-beta dehydrogenase 13 |
| ICAM-1 | intercellular adhesion molecule-1 |
| IL | interleukin |
| JNK | c-Jun NH2-terminal kinase |
| KLF2 | Krüppel-like Factor 2 |
| LDLr−/− | low-density lipoprotein receptor deficient |
| LOX-1 | lectin-like oxLDL receptor-1 |
| Lp(a) | lipoprotein (a) |
| MACE | major adverse cardiovascular event |
| MBOAT7 | membrane-bound O-acyltransferase domain-containing 7 |
| MCP-1 | monocyte chemoattractant protein-1 |
| MetS | metabolic syndrome |
| MMPs | matrix metalloproteinases |
| MRI | magnetic resonance imaging |
| NAFLD | nonalcoholic fatty liver disease |
| NAS | NAFLD activity score |
| NASH | nonalcoholic steatohepatitis |
| NASH CRN | NASH Clinical Research Network |
| NCEH | neutral cholesterol ester hydrolase |
| NK | natural killer |
| NLRP3 | NOD-like receptor protein 3 |
| NLRs | NOD-like receptors |
| oxLDL | oxidized low-density lipoprotein |
| PAI-1 | plasminogen activator inhibitor-1 |
| PAMPs | pathogen-associated molecular patterns |
| PDFF | proton density fat fraction |
| PDGF | platelet-derived growth factor |
| PNPLA3 | patatin-like phospholipase domain-containing 3 |
| PRRs | pattern recognition receptors |
| PUFAs | polyunsaturated fatty acids |
| PYGO1 | Pygopus family PHD finger 1 |
| ROS | reactive oxygen species |
| SCFAs | short-chain fatty acids |
| SR | scavenger receptor |
| T2DM | type 2 diabetes mellitus |
| TGF-β1 | transforming growth factor |
| TGR5 | G-protein-coupled receptor 5 |
| TGs | triglycerides |
| TIMP-1 | tissue inhibitor of metalloproteinases 1 |
| TIMPs | tissue inhibitor of metalloproteinases |
| TLRs | toll-like receptors |
| TM6SF2 | transmembrane 6 super-family member 2 |
| TNF-a | tumor necrosis factor-a |
| VCAM-1 | vascular cell adhesion molecule |
| VLDL | very low density lipoproteins |
| VSMC | vascular smooth muscle cells |